10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q1 2018

Filing Information

Form Type	10-Q
Accession Number	`0001683168-18-001382`
Period End Date	20180331
Filing Date	20180515
Fiscal Year	2018
Fiscal Period	Q1
XBRL Instance	xbio-20180331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 18 Cash Flow Statement 42

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.04M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.04M	shares	Point-in-time
Cash	`Cash`	$5.53M	USD	Point-in-time
Cash	`Cash`	$3.87M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.72M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.72M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$285.00K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$343.44K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$5.88M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.28M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$22.12K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.85K	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$724.71K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$718.16K	USD	Point-in-time
Total assets	`Assets`	$19.16M	USD	Point-in-time
Total assets	`Assets`	$17.54M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$896.43K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$786.78K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$826.55K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.14M	USD	Point-in-time
Other current liabilities	`DeferredCreditsAndOtherLiabilitiesCurrent`	$21.23K	USD	Point-in-time
Other current liabilities	`DeferredCreditsAndOtherLiabilitiesCurrent`	$16.37K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.74M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.94M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.86M	USD	Point-in-time
Commitments and contingent liabilities (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingent liabilities (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of March 31, 2018 and December 31, 2017; 9,041,426 and 9,041,426 shares issued as of March 31, 2018 and December 31, 2017, respectively; 8,717,541 and 8,717,541 shares outstanding as of March 31, 2018 and December 31, 2017, respectively	`CommonStockValue`	$9.04K	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of March 31, 2018 and December 31, 2017; 9,041,426 and 9,041,426 shares issued as of March 31, 2018 and December 31, 2017, respectively; 8,717,541 and 8,717,541 shares outstanding as of March 31, 2018 and December 31, 2017, respectively	`CommonStockValue`	$9.04K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$165.66M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$165.25M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-145.93M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-147.76M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.89M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.30M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.16M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$17.54M	USD	Point-in-time

Income Statement 18 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$1.22M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$706.27K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.63M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.12M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.86M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.83M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$5.40K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-9.36K	USD	1 Quarter
Interest income (expense)	`InterestIncomeExpenseNet`	$427.00	USD	1 Quarter
Interest income (expense)	`InterestIncomeExpenseNet`	$-588.00	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$5.83K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-9.94K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.87M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.82M	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.21	USD	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.52M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.72M	shares	1 Quarter

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.87M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.82M	USD	1 Quarter
Depreciation	`Depreciation`	$7.71K	USD	1 Quarter
Depreciation	`Depreciation`	$5.72K	USD	1 Quarter
Share-based payments	`ShareBasedCompensation`	$650.27K	USD	1 Quarter
Share-based payments	`ShareBasedCompensation`	$383.85K	USD	1 Quarter
Warrant expense for services	`AdjustmentOfWarrantsGrantedForServices`	$4.92K	USD	1 Quarter
Warrant expense for services	`AdjustmentOfWarrantsGrantedForServices`	$-15.35K	USD	1 Quarter
Vendor share-based payments	`VendorSharebasedPayments`	$31.07K	USD	1 Quarter
Vendor share-based payments	`VendorSharebasedPayments`	$17.43K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$584.56K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$51.89K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-204.31K	USD	1 Quarter
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$57.28K	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$280.81K	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.67M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.43K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.43K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$275.38K	USD	1 Quarter
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.67M	USD	1 Quarter
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.93M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.05M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.32M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.93M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.05M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.32M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$671.00	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$599.00	USD	1 Quarter
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	-	USD	1 Quarter
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	$120.00	USD	1 Quarter
Reclassification of common shares issuable to accounts payable	`ReclassificationOfCommonSharesIssuableToAccountsPayable`	$65.98K	USD	1 Quarter
Reclassification of common shares issuable to accounts payable	`ReclassificationOfCommonSharesIssuableToAccountsPayable`	-	USD	1 Quarter
Issuance of common stock for promissory note converted in 2016	`IssuanceOfCommonStockForPromissoryNoteConvertedIn2016`	-	USD	1 Quarter
Issuance of common stock for promissory note converted in 2016	`IssuanceOfCommonStockForPromissoryNoteConvertedIn2016`	$125.00	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.